FIESLs demonstrated an anti-obesity effect against an HFD by regulating body weight, epididymal fat, blood glucose, leptin, and serum biomarkers such as total lipid, triglyceride, and total cholesterol, in addition to modulating gut microbiota composition. The gene discussed is LEP; the disease is obesity disorder.